Jing Marantz
Patrimonio netto: 6 M $ in data 31/05/2026
Patrimonio netto: 6 M $ in data 31/05/2026
La dottoressa Jing L. Marantz è vicepresidente senior degli affari medici presso Acceleron Pharma, Inc. Fa parte del consiglio di amministrazione di Krystal Biotech, Inc. La dottoressa Marantz è stata precedentemente impiegata come responsabile degli affari medici e vicepresidente senior presso Alnylam Pharmaceuticals, Inc., vicepresidente degli affari medici presso ARIAD Pharmaceuticals, Inc. e vicepresidente degli affari medici globali presso Alexion Pharmaceuticals, Inc. Ha ricevuto il suo MBA dalla Haas School of Business, un dottorato dal Tongji Medical College of Huazhong University of Sci & Tech e un dottorato dalla Medical University of South Carolina.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 17/02/2026 | 126.012 ( 0,11% ) | 6 M $ | 31/05/2026 | |
| 05/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Direttore/Membro del Consiglio | 07/12/2021 |
| SCHOLAR ROCK HOLDING CORPORATION | Direttore Tecnico/Scientifico/R&S | 09/11/2022 |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Direttore/Membro del Consiglio | - |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| KRYSTAL BIOTECH, INC. | Direttore/Membro del Consiglio | 18/01/2022 |
| ACCELERON PHARMA INC. | Direttore Tecnico/Scientifico/R&S | 01/11/2021 |
| ALNYLAM PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2020 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/06/2018 |
| ARIAD PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Medical University of South Carolina
Medical University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Krystal Biotech, Inc.
Krystal Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops gene therapies to patients living with debilitating diseases | Health Technology |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Scholar Rock Holding Corp.
Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Arcturus Therapeutics Holdings, Inc.
Arcturus Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale